Unraveling the Ownership: Who makes Brodalumab?
•
2 min read
Originally developed by Amgen, the biologic medication brodalumab underwent several key ownership changes before its market debut, creating a complex manufacturing and commercialization landscape. The answer to who makes brodalumab depends heavily on the geographic region, as different pharmaceutical companies hold marketing rights in different parts of the world.